Company Filing History:
Years Active: 2022-2024
Title: Franz Fenninger: Innovator in Antibody Research
Introduction
Franz Fenninger is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of antibody research, particularly in the development of antibodies targeting L-type voltage-gated calcium channels. With a total of 2 patents, his work has implications for cancer treatment and immune response modification.
Latest Patents
Fenninger's latest patents include innovative methods and compositions related to antibodies that specifically bind to an extracellular poor loop of an alpha 1a subunit of L-type voltage-gated calcium channels. These antibodies and their antigen-binding fragments are designed for administration to subjects in need, aiming to modify immune responses, particularly in the context of cancer treatment.
Career Highlights
Franz Fenninger is affiliated with the University of British Columbia, where he conducts his research and development work. His academic background and ongoing research contribute to advancements in medical science, particularly in immunology and cancer therapy.
Collaborations
Fenninger collaborates with esteemed colleagues such as Wilfred A Jefferies and Kyung Bok Choi. Their combined expertise enhances the research efforts and fosters innovation in the field.
Conclusion
Franz Fenninger's work exemplifies the intersection of innovation and medical research, particularly in the development of targeted therapies for cancer. His contributions continue to shape the future of antibody research and its applications in healthcare.